Literature DB >> 24163010

Serum hyaluronic acid concentration in Fontan circulation: correlation with hepatic function and portal vein hemodynamics.

Taiyu Hayashi1, Ryo Inuzuka, Takahiro Shindo, Yoichiro Hirata, Nobutaka Shimizu, Akira Oka.   

Abstract

Although liver fibrosis causes significant morbidity in the late postoperative period of the Fontan procedure, the diagnostic value of hyaluronic acid (HA), a serum marker of liver fibrosis, has not been established in Fontan patients. The purpose of this study was to determine whether increased serum HA concentration in Fontan patients is associated with an increase in inspiratory-to-expiratory flow rate ratio (Qin/Qex) of the portal vein (PV), which is indicative of liver fibrosis. We retrospectively studied 28 consecutive patients with Fontan circulation who underwent cardiac catheterisation for various indications. The median age at examination was 5.5 years (range 2.2-5.6). The median HA concentration was 17.7 ng mL(-1) (range 10.0-82.1), which was used to divide our 28 patients into two groups. Patients in the high-HA group had significantly greater Qin/Qex of the PV than those in the low-HA group (1.25 ± 0.12 vs. 1.12 ± 0.11, p < 0.05). Platelet counts were significantly lower in the high-HA group (216 ± 74 vs. 294 ± 104 × 10(9) L(-1), p < 0.05). No significant difference was found in inferior vena caval pressure. In conclusion, increase of HA concentration in Fontan patients accompanies the change in PV hemodynamics peculiar to liver cirrhosis and might be an early indicator of liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24163010     DOI: 10.1007/s00246-013-0827-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Portal venous blood flow while breath-holding after inspiration or expiration and during normal respiration in controls and cirrhotics.

Authors:  S Sugano; K Yamamoto; K Sasao; M Watanabe
Journal:  J Gastroenterol       Date:  1999-10       Impact factor: 7.527

2.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

3.  Non-invasive assessment of liver fibrosis in patients after the Fontan operation.

Authors:  Takeshi Furukawa; Katsumi Akimoto; Masahiro Ohtsuki; Keiko Sato; Mitsuyoshi Suzuki; Ken Takahashi; Masahiko Kishiro; Toshiaki Shimizu; Shiori Kawasaki
Journal:  Pediatr Int       Date:  2011-12       Impact factor: 1.524

4.  Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery.

Authors:  Matthew C Schwartz; Lisa M Sullivan; Andrew C Glatz; Elizabeth Rand; Pierre Russo; David J Goldberg; Jonathan J Rome; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2012-06-14       Impact factor: 1.655

5.  Magnetic resonance imaging identifies unsuspected liver abnormalities in patients after the Fontan procedure.

Authors:  Ozlem Pinar Bulut; Rene Romero; William T Mahle; Michael McConnell; Kiery Braithwaite; Bahig M Shehata; Nitika A Gupta; Miriam Vos; Adina Alazraki
Journal:  J Pediatr       Date:  2013-02-04       Impact factor: 4.406

6.  Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.

Authors:  Shi-Bin Xie; Ji-Lu Yao; Rong-Qin Zheng; Xiao-Mou Peng; Zhi-Liang Gao
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-02

Review 7.  Sonography of diffuse liver disease.

Authors:  Hisham Tchelepi; Philip W Ralls; Randall Radin; Edward Grant
Journal:  J Ultrasound Med       Date:  2002-09       Impact factor: 2.153

8.  Expression of hyaluronic acid in N-nitrosodimethylamine induced hepatic fibrosis in rats.

Authors:  Joseph George; Mikihiro Tsutsumi; Shujiro Takase
Journal:  Int J Biochem Cell Biol       Date:  2004-02       Impact factor: 5.085

Review 9.  The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium.

Authors:  Jack Rychik; Gruschen Veldtman; Elizabeth Rand; Pierre Russo; Jonathan J Rome; Karen Krok; David J Goldberg; Anne Marie Cahill; Rebecca G Wells
Journal:  Pediatr Cardiol       Date:  2012-04-26       Impact factor: 1.655

10.  The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.

Authors:  Pamela Valva; Paola Casciato; Juan M Diaz Carrasco; Adrian Gadano; Omar Galdame; María Cristina Galoppo; Eduardo Mullen; Elena De Matteo; María Victoria Preciado
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

View more
  3 in total

1.  Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.

Authors:  Gaku Izumi; Atsuhito Takeda; Hirokuni Yamazawa; Osamu Sasaki; Nobuyasu Kato; Hidetsugu Asai; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

2.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

3.  Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.

Authors:  William N Evans; Brody J Winn; Noel S Yumiaco; Alvaro Galindo; Abraham Rothman; Ruben J Acherman; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2014-05-10       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.